Milrinone for Free Flap Surgery
Phase 3
Completed
- Conditions
- Free flap surgerySurgery - Other surgery
- Registration Number
- ACTRN12605000640606
- Lead Sponsor
- Department of Anaesthesia, St Vincent's Hospital Melbourne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Elective patients for free flap surgery.Serious cardiac disease, stenotic or ischaemic cardiac disease and history of ventricular arrhythmias.Previous adverse reaction or allergy to milrinone.Renal impairment Cr > 0.15 mmol/L.
Exclusion Criteria
Inability to give informed consent and patient refusal.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Milrinone phosphodiesterase 3 inhibition mechanism preventing vasospasm microvascular free flap surgery
Comparative effectiveness Milrinone versus other vasodilators free flap surgery vasospasm prevention
Predictive factors vasospasm risk Milrinone efficacy free flap microvascular anastomosis outcomes
Systemic hemodynamic effects adverse events intraoperative Milrinone infusion free flap reconstruction
Alternative pharmacological non-pharmacological strategies preventing microvascular thrombosis free flap failure surgery